# CYA Versus MMF for Treatment of Moderate-Severe Psoriasis.

> **NCT00295425** · PHASE2 · UNKNOWN · sponsor: **University Hospital Muenster** · enrollment: 50 (—)

## Conditions studied

- Psoriasis

## Interventions

- **DRUG:** Cyclosporine A versus mycophenolate mofetil for psoriasis

## Key facts

- **NCT ID:** NCT00295425
- **Lead sponsor:** University Hospital Muenster
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2000-05
- **Primary completion:** —
- **Final completion:** 2006-10
- **Target enrollment:** 50 (—)
- **Last updated:** 2006-10-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00295425

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00295425, "CYA Versus MMF for Treatment of Moderate-Severe Psoriasis.". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00295425. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*